<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02169154</url>
  </required_header>
  <id_info>
    <org_study_id>202187</org_study_id>
    <secondary_id>RH02170</secondary_id>
    <nct_id>NCT02169154</nct_id>
  </id_info>
  <brief_title>A Safety Study to Investigate the Skin Irritancy Potential of Diclofenac-Menthol Gel</brief_title>
  <official_title>A Cumulative Skin Irritation Study Investigating the Skin Irritancy Potential of MFC51123 Diclofenac-Menthol Gel</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>GlaxoSmithKline</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>GlaxoSmithKline</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This research study is being conducted to investigate the skin irritancy potential of a new
      medication which contains two active ingredients (diclofenac and menthol) together in a gel
      formulation and is being developed to treat mild to moderate pain and inflammation, such as
      acute sport injuries, sprains and strains.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Approximately 36 healthy subject volunteers will be exposed to seven test products (study
      treatment gel and six control products) simultaneously for 21 consecutive days. The seven
      test products will be applied using a 7-channel patch assembly that will be affixed to the
      infrascapular areas of the back of each subject for approximately 24 hours daily.

      The subject will return to the clinic to undergo a skin irritation assessment at
      approximately 24 hours after the time the patch assembly was initially affixed.

      During the visits, doctors or trained staff members will examine the signs of irritation (if
      any) of the skin where the test products are applied. The skin irritation assessment will
      primarily characterize the test products individually in terms of symptomatology using a
      7-point categorical scale ranging from 1 (glazing and/or wrinkling) to 7 (erosion and/or
      vesiculation).
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 1, 2014</start_date>
  <completion_date type="Actual">July 1, 2014</completion_date>
  <primary_completion_date type="Actual">July 1, 2014</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Treatment mean cumulative irritation score</measure>
    <time_frame>Day 21</time_frame>
    <description>Cumulative irritation scores will be defined daily as the sum of irritation score and grade number</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Adverse event assessment</measure>
    <time_frame>21 days + 5 days follow-up</time_frame>
    <description>Adverse events will be graded on a three-point scale: 1. Mild-easily tolerated, causing minimal discomfort and not interfering with normal everyday activities; 2. Moderate-sufficiently discomforting to interfere with normal everyday activities; 3. Severe-any event that prevents normal everyday activities</description>
  </primary_outcome>
  <number_of_arms>7</number_of_arms>
  <enrollment type="Actual">36</enrollment>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>Diclofenac Sodium/Menthol Gel</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>1% diclofenac sodium + 3% menthol</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Diclofenac Gel</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>1% diclofenac sodium + 0.09% menthol</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Menthol Gel</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>3% menthol</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo Gel</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>0.09% menthol</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Voltaren Gel</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>1% diclofenac sodium</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sodium lauryl sulfate</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>0.2% Sodium lauryl sulfate</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Saline</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>0.9% saline</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>1% Diclofenac Sodium</intervention_name>
    <description>1% diclofenac sodium</description>
    <arm_group_label>Diclofenac Sodium/Menthol Gel</arm_group_label>
    <arm_group_label>Voltaren Gel</arm_group_label>
    <arm_group_label>Diclofenac Gel</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>3% Menthol</intervention_name>
    <description>3% Menthol</description>
    <arm_group_label>Diclofenac Sodium/Menthol Gel</arm_group_label>
    <arm_group_label>Menthol Gel</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>0.09% Menthol</intervention_name>
    <description>0.09% Menthol</description>
    <arm_group_label>Placebo Gel</arm_group_label>
    <arm_group_label>Diclofenac Gel</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>0.2% Sodium Lauryl Sulfate</intervention_name>
    <description>0.2% Sodium Lauryl Sulfate</description>
    <arm_group_label>Sodium lauryl sulfate</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>0.9% Saline</intervention_name>
    <description>0.9% Saline</description>
    <arm_group_label>Saline</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male/female volunteer â‰¥18 years

          -  No systemic/dermatologic disorder

        Exclusion Criteria:

          -  Visible skin disease at the site of application that might interfere with skin
             assessments

          -  Allergy or hypersensitivity to NSAIDs or menthol or any of the excipients in the test
             product

          -  History of physical or psychiatric illness, or medical disorder

          -  Recent history of alcohol or drug abuse

          -  Pregnant or lactating females
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>GSK Clinical Trials</last_name>
    <role>Study Director</role>
    <affiliation>GlaxoSmithKline</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>TKL Research Inc</name>
      <address>
        <city>Paramus</city>
        <state>New Jersey</state>
        <zip>07652</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://www.gsk-clinicalstudyregister.com/study/202187?search=study&amp;search_terms=202187#rs</url>
    <description>Results for the study 202187 can be found on the GSK Clinical Study Register.</description>
  </link>
  <verification_date>June 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 19, 2014</study_first_submitted>
  <study_first_submitted_qc>June 19, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 23, 2014</study_first_posted>
  <last_update_submitted>June 28, 2017</last_update_submitted>
  <last_update_submitted_qc>June 28, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">June 29, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diclofenac</mesh_term>
    <mesh_term>Menthol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

